“Pharma lacks engagement with mental health groups.” Such headlines are no strangers to the recent mental health coverage that we surveyed. We found that while the general awareness of mental health issues is rapidly increasing, pharma’s reputation in this area suffers from some major setbacks. Research And Markets’ study Corporate Reputation of Pharma Companies, 2017-2018 … Continue reading “Pharma and Mental Health: Reputation Challenges”
The global Alzheimer’s drugs market was valued at around $3.64 billion last year and is expected to generate revenues of $5.66 billion by the end of 2024, with a compound annual growth rate of around 8% between 2018 and 2024. This is the conclusion of Zion Market Research’s latest report on the evolving financial nature … Continue reading “Alzheimer’s in the Media: The Power of Influencers”
In their latest study on the pharma market, intelligence provider Evaluate pointed out that the development and commercialisation of gene and cell therapies is turning into a powerful engine of value creation for pharma companies. The launch of these novel therapies is also instrumental in fueling the global growth of the market, where total prescription … Continue reading “The Future of Pharma? Mapping the Gene Therapy Trend”
A recent research conducted by PwC and CB Insights found that venture capitalists invested $10.6 billion into healthcare start-ups in the first half of 2018, with $5.3 billion spent in 216 healthcare deals in the second quarter of the year – a 21% increase from the first quarter and a 49% increase from the same … Continue reading “Pharma start-ups in the media: communicating the industry’s future”
“Part of our competitors are not only the Novartis of the world and the other pharmas, but really the Amazons and Googles,” Yitzhak Peterburg, the former CEO of pharmaceutical giant Teva, said a year ago, adding that the global healthcare sector is facing a “huge disruption” by tech giants which start competing with traditional players … Continue reading “Big Pharma vs Big Tech: Healthcare Innovation Trends in the Media”
As with the Brexit quandary, the economic turbulence surrounding the US-China trade skirmish presents an opportunity for many corporates to boost their brand presence in the media by establishing themselves as thought leaders. When reporting on the trade tensions between the two largest economies, journalists naturally reach out to quantitative analyses and expert studies, and … Continue reading “US-China Trade War 2: Thought Leaders on the Battleground”
As the two largest national economies embroil in a trade showdown, it is individual companies which are in the centre of extensive reportages and economic commentary: the dispute is not just between the two countries, but also between corporations and policy makers, as the former are usually opposed to protectionist approaches. In the accelerating tit-for-tat … Continue reading “US-China Trade War: Corporate Communications in the Battlefields”
Alongside finance and law, the industry which occupies a central place in the heated Brexit debates is the life sciences. From the infamous campaign bus which hit the road with Vote Leave’s empty promise about £350 million a week for the National Health Service to the latest ominous warnings of post-Brexit shortages of drugs and … Continue reading “Brexit in the Media 3: Life Science PR in Unhealthy Climate”
Having examined the way banks promote themselves in the Brexit media coverage, we will now turn to an industry which works hand in glove with financial giants – law. UK’s affluent legal market is fueled by London’s role as a global financial hub, and bankers form the biggest client pool for lawyers: according to the … Continue reading “Brexit in the Media 2: Expert Opinion on Legal PR”
